Pew Supports Proposed Rule to Broaden Treatment Access in Kentucky

Research backs more flexible policies for opioid treatment programs

Pew Supports More Flexible Regulations in Kentucky

On Oct. 4, The Pew Charitable Trusts submitted public comments in support of proposed regulations in Kentucky (908 KAR 1:374) that aim to make evidence-based treatment for opioid use disorder (OUD) more widely available and better aligned with federal regulations. Specifically, the regulations apply to opioid treatment programs (OTPs) that administer methadone, one of three FDA-approved medications to treat OUD. The regulation would grant key flexibilities—including reduced drug screenings, removal of counseling requirements and involuntary discharge as a result of a positive drug screen, and expanded take-home dosing—to OTP patients so that they are more likely to stay in treatment and receive lifesaving medication. Pew’s comment letter follows its technical assistance work in Kentucky as well as policy recommendations to strengthen the state’s treatment system.

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.